Sanofi unit Genzyme and Veracyte, Inc. entered a global co-promotion partnership aimed at providing a comprehensive solution for thyroid patients. The agreement will give patients worldwide increased access to an advanced personalized medicine for improved diagnosis of thyroid nodules, and has the potential to reduce the number of unnecessary thyroidectomies. Genzyme will market and promote Veracyte’s Afirma Thyroid FNA Analysis, an innovative approach for improved thyroid nodule diagnosis, in ...